Clearside Biomedical (CLSD) had the highest return between September 14, 2016 and October 15, 2016 by a US stock, returning 154.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Clearside Biomedical (CLSD) | 9/14/2016 - 10/15/2016 | 154.87% |
Renovaro Biosciences (RENB) | 9/14/2016 - 10/15/2016 | 150% |
Cronos (CRON) | 9/14/2016 - 10/15/2016 | 121.95% |
Nova Lifestyle I (NVFY) | 9/14/2016 - 10/15/2016 | 110.8% |
CEA Industries (CEAD) | 9/14/2016 - 10/15/2016 | 101.66% |
OLB (OLB) | 9/14/2016 - 10/15/2016 | 100% |
Aurinia Pharmaceuticals (AUPH) | 9/14/2016 - 10/15/2016 | 98.1% |
Aurora Cannabis (ACB) | 9/14/2016 - 10/15/2016 | 96.78% |
Fubotv (FUBO) | 9/14/2016 - 10/15/2016 | 95% |
Datasea (DTSS) | 9/14/2016 - 10/15/2016 | 89.87% |
Collegium Pharmaceutical (COLL) | 9/14/2016 - 10/15/2016 | 89.22% |
TSS, Inc Common Stock (TSSI) | 9/14/2016 - 10/15/2016 | 84.89% |
Alpha Metallurgical Resources (AMR) | 9/14/2016 - 10/15/2016 | 83.44% |
Hepion Pharmaceuticals (HEPA) | 9/14/2016 - 10/15/2016 | 81.48% |
Bone Biologics (BBLG) | 9/14/2016 - 10/15/2016 | 80.9% |
Anixa Biosciences (ANIX) | 9/14/2016 - 10/15/2016 | 80.06% |
Summit Therapeutics (SMMT) | 9/14/2016 - 10/15/2016 | 78.2% |
InMed Pharmaceuticals (INM) | 9/14/2016 - 10/15/2016 | 77.22% |
Sarepta Therapeutics (SRPT) | 9/14/2016 - 10/15/2016 | 76.32% |
Merus (MRUS) | 9/14/2016 - 10/15/2016 | 75.28% |
Eledon Pharmaceuticals (ELDN) | 9/14/2016 - 10/15/2016 | 66% |
Processa Pharmaceuticals (PCSA) | 9/14/2016 - 10/15/2016 | 65.75% |
XWELL (XWEL) | 9/14/2016 - 10/15/2016 | 65.12% |
SurgePays (SURG) | 9/14/2016 - 10/15/2016 | 63.93% |
Protagonist Therapeutics (PTGX) | 9/14/2016 - 10/15/2016 | 62.82% |
